Benzinga | Jun 8, 2021 01:27PM EDT

Aptinyx Granted U.S. Patent Titled 'Spiro-lactam and bis-spiro-lactam NMDA receptor modulators and uses thereof'

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=5559&f=G&l=50&d=PTXT&p=112&S1=20210608&OS=20210608&RS=20210608